Package 42291-011-01

Brand: amlodipine and benazepril hydrochloride

Generic: amlodipine and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 42291-011-01
Digits Only 4229101101
Product NDC 42291-011
Description

100 CAPSULE in 1 BOTTLE (42291-011-01)

Marketing

Marketing Status
Marketed Since 2023-06-20
Brand amlodipine and benazepril hydrochloride
Generic amlodipine and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3c1cb59c-965a-92df-e063-6394a90a7b0a", "openfda": {"upc": ["0041000006883"], "unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898353", "898356", "898359"], "spl_set_id": ["fe91d607-5e1f-48e4-e053-6294a90ac522"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (42291-011-01)", "package_ndc": "42291-011-01", "marketing_start_date": "20230620"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "42291-011_3c1cb59c-965a-92df-e063-6394a90a7b0a", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "42291-011", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20230620", "listing_expiration_date": "20261231"}